Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT03906604
Other study ID # 18-010050
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date February 5, 2019
Est. completion date July 27, 2020

Study information

Verified date April 2022
Source Mayo Clinic
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

To compare the incisionless thread carpal tunnel release with the standard mini-open carpal tunnel release (standard of care) in patients with bilateral carpal tunnel syndrome. Patients with bilateral CTS will have one side released with incisionless thread carpal tunnel release and the contralateral side released with the mini-open carpal tunnel release. The investigators hypothesize that the incisionless thread carpal tunnel release (TCTR) will be no different than the standard mini-open release (MOR) with regard to symptom improvement and safety and will be less painful, result in quicker return to work and will be less costly.


Recruitment information / eligibility

Status Terminated
Enrollment 11
Est. completion date July 27, 2020
Est. primary completion date July 27, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - A diagnosis of bilateral CTS with symptoms including pain, paresthesia's, and weakness of the hand in the median nerve distribution for minimum of 3 months - Willingness to undergo bilateral carpal tunnel surgical treatment with one side having the TCTR and the other a mini open carpal tunnel release - Age 18-65 years of age - Clinical examination findings (compression test, Tinels, Phalens, etc) consistent with carpal tunnel syndrome. - Persistence of symptoms after 6 weeks of conservative treatment such as splinting, activity modification, and/or injection therapy. - Electromyographic evidence of mild, moderate, moderately severe, or severe median nerve neuropathy at the wrist - Able and willing to complete all follow-up appointments Exclusion Criteria: - Previous CTS surgical release on any of their hands - Diabetes mellitus - Hypothyroidism - Significant Hand arthritis (rheumatologic or osteoarthritis) - Pregnancy - Electromyographic evidence of any condition other than CTS affecting the hand - Workman's compensation

Study Design


Intervention

Procedure:
Carpal Tunnel Procedure (open)
Patients with bilateral CTS will have one side released with incisionless thread carpal tunnel release and the contralateral side released with the mini-open carpal tunnel release.

Locations

Country Name City State
United States Mayo Clinic Rochester Minnesota

Sponsors (1)

Lead Sponsor Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

References & Publications (10)

Fajardo M, Kim SH, Szabo RM. Incidence of carpal tunnel release: trends and implications within the United States ambulatory care setting. J Hand Surg Am. 2012 Aug;37(8):1599-605. doi: 10.1016/j.jhsa.2012.04.035. Epub 2012 Jun 23. — View Citation

Greenslade JR, Mehta RL, Belward P, Warwick DJ. Dash and Boston questionnaire assessment of carpal tunnel syndrome outcome: what is the responsiveness of an outcome questionnaire? J Hand Surg Br. 2004 Apr;29(2):159-64. — View Citation

Guo D, Guo D, Guo J, Malone DG, Wei N, McCool LC. A Cadaveric Study for the Improvement of Thread Carpal Tunnel Release. J Hand Surg Am. 2016 Oct;41(10):e351-e357. doi: 10.1016/j.jhsa.2016.07.098. Epub 2016 Aug 20. — View Citation

Guo D, Guo D, Guo J, Schmidt SC, Lytie RM. A Clinical Study of the Modified Thread Carpal Tunnel Release. Hand (N Y). 2017 Sep;12(5):453-460. doi: 10.1177/1558944716668831. Epub 2016 Sep 12. — View Citation

Guo D, Tang Y, Ji Y, Sun T, Guo J, Guo D. A non-scalpel technique for minimally invasive surgery: percutaneously looped thread transection of the transverse carpal ligament. Hand (N Y). 2015 Mar;10(1):40-8. doi: 10.1007/s11552-014-9656-4. — View Citation

Huisstede BM, Hoogvliet P, Randsdorp MS, Glerum S, van Middelkoop M, Koes BW. Carpal tunnel syndrome. Part I: effectiveness of nonsurgical treatments--a systematic review. Arch Phys Med Rehabil. 2010 Jul;91(7):981-1004. doi: 10.1016/j.apmr.2010.03.022. Review. — View Citation

Huisstede BM, Randsdorp MS, Coert JH, Glerum S, van Middelkoop M, Koes BW. Carpal tunnel syndrome. Part II: effectiveness of surgical treatments--a systematic review. Arch Phys Med Rehabil. 2010 Jul;91(7):1005-24. doi: 10.1016/j.apmr.2010.03.023. Review. — View Citation

Kim PT, Lee HJ, Kim TG, Jeon IH. Current approaches for carpal tunnel syndrome. Clin Orthop Surg. 2014 Sep;6(3):253-7. doi: 10.4055/cios.2014.6.3.253. Epub 2014 Aug 5. Review. — View Citation

Michelotti B, Romanowsky D, Hauck RM. Prospective, randomized evaluation of endoscopic versus open carpal tunnel release in bilateral carpal tunnel syndrome: an interim analysis. Ann Plast Surg. 2014 Dec;73 Suppl 2:S157-60. doi: 10.1097/SAP.0000000000000203. — View Citation

Papanicolaou GD, McCabe SJ, Firrell J. The prevalence and characteristics of nerve compression symptoms in the general population. J Hand Surg Am. 2001 May;26(3):460-6. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Boston Carpal Tunnel Syndrome Questionnaire (BCTQ) functional score Measured on a symptom severity scale from 1 to 5, where 1 is normal and 5 is very serious/continued/difficult Change from Baseline to 12 months
Primary Visual analog pain scale Pain that participant is currently experiencing the in the hand or risk(0-100) Change from Baseline to 12 months
Primary Strength testing of grip and pinch Use dynameters and pinch meters Change from Baseline to 12 months
Primary Disability of the Arm Shoulder Hand DASH he disabilities of the arm, shoulder and hand (DASH) questionnaire is a self-administered region-specific outcome instrument developed as a measure of self-rated upper-extremity disability and symptoms. The DASH consists mainly of a 30-item disability/symptom scale, scored 0 (no disability) to 100. The main purpose of this study was to assess the longitudinal construct validity of the DASH among patients undergoing surgery. The second purpose was to quantify self-rated treatment effectiveness after surgery. Change from Baseline to 12 months
See also
  Status Clinical Trial Phase
Completed NCT04347746 - Comparison of Interventions in Patients With Carpal Tunnel Syndrome N/A
Completed NCT03213847 - Superb Microvascular Imaging of Median Nerve in Carpal Tunnel Syndrome: A Novel Technique in Diagnostic Ultrasound N/A
Recruiting NCT04890119 - Prevalence Study of Amyloidosis in Patients With Surgery of Suspect Bilateral Carpal Tunnel (AMYLYONCARP) N/A
Completed NCT05808855 - Neurological Outcomes Following Carpal Tunnel Wound-closure Techniques N/A
Completed NCT03532373 - Testing of a Tool to Elicit Patient Preferences for CTS N/A